Prohibition of 16 fixed-dose combinations

One line

The Health Ministry prohibited the manufacture, sale, and distribution of 16 fixed-dose combinations in the public interest.

Summary

Combining medicines can improve adherence when clinically justified, but irrational combinations may add side effects, interactions, or antimicrobial-resistance pressure without adequate benefit.

PYQ pattern

UPSC can connect pharmaceutical regulation with public health, federal enforcement, affordability, and antimicrobial resistance.

Core notes

An FDC contains two or more active ingredients in a fixed ratio.
Regulation considers safety, efficacy, therapeutic justification, and available alternatives.
A prohibition applies to specified formulations, not automatically to every medicine containing one component.
Pharmacovigilance and prescription quality remain important after market approval.

Prelims lens

CDSCO is the national drug-regulatory organisation under the Health Ministry.
Drug approval and market surveillance are separate stages.
Antimicrobial resistance can be worsened by unnecessary antimicrobial exposure.

MCQ 1

A fixed-dose combination contains:

A. Multiple active ingredients in a fixed ratio
B. Only a change in package colour
C. No active ingredient
D. A vaccine and diagnostic device in every case

Reveal answer

A

The defining feature is two or more active ingredients combined in fixed proportions.

MCQ 2

Prohibiting a specified FDC means:

A. All medicines are prohibited
B. The named formulation cannot be manufactured, sold, or distributed under the order
C. Pharmacovigilance is unnecessary
D. Every individual ingredient is automatically banned

Reveal answer

B

The action targets the notified combinations.

Mains

Question, 10 marks, 150 words: Why is post-market review essential for pharmaceutical regulation?

Approach:

Explain limits of pre-approval evidence.
Discuss adverse-event and prescribing data.
Use irrational FDCs and AMR as examples.
Suggest transparent review and enforcement.